{"organizations": [], "uuid": "4986c46813eea11521424131f9a7605e9bc23dd3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "in.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?d=20180425&i=OV8CXH097&w=1200&r=OV8CXH097&t=2", "site_section": "http://feeds.reuters.com/reuters/INVideoBusiness", "section_title": "Reuters Video: Business", "url": "https://in.reuters.com/video/2018/04/25/takeda-sweetens-the-pill-for-shire-with?videoId=421101581", "country": "US", "domain_rank": 408, "title": "Takeda sweetens the pill for Shire with $64 billion takeover offer", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T14:58:00.000+03:00", "replies_count": 0, "uuid": "4986c46813eea11521424131f9a7605e9bc23dd3"}, "author": "", "url": "https://in.reuters.com/video/2018/04/25/takeda-sweetens-the-pill-for-shire-with?videoId=421101581", "ord_in_thread": 0, "title": "Takeda sweetens the pill for Shire with $64 billion takeover offer", "locations": [], "entities": {"persons": [{"name": "takeda", "sentiment": "negative"}, {"name": "silvia antonioli", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}], "locations": [{"name": "japan", "sentiment": "none"}], "organizations": [{"name": "shire", "sentiment": "negative"}, {"name": "takeda", "sentiment": "negative"}, {"name": "takeda pharmaceutical co", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Takeda sweetens the pill for Shire with $64 billion takeover offer Wednesday, April 25, 2018 - 01:51\nRare disease specialist Shire says it is willing to recommend a sweetened $64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company this year. Silvia Antonioli reports.\nRare disease specialist Shire says it is willing to recommend a sweetened $64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company this year. Silvia Antonioli reports. //reut.rs/2r0ZSDM", "external_links": [], "published": "2018-04-25T14:58:00.000+03:00", "crawled": "2018-04-25T15:45:16.000+03:00", "highlightTitle": ""}